GRCE financials

Grace Therapeutics (GRCE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

GRCE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026––-$11.08M-$7.79M-0.47
2025––-$16.68M-$9.57M-0.79
2024––-$12.85M-$12.85M-1.35
2023––-$52.16M-$42.43M-5.71
2022$0.00$0.00-$15.59M-$9.82M-1.62
2021$196.00K$120.00K-$16.42M-$19.68M-7.98